Greenlane Cuts Q3 Net Loss Despite 66% Revenue Drop, Shifts Product Strategy
Greenlane Cuts Q3 Net Loss Despite 66% Revenue Drop, Shifts Product Strategy
Greenlane Holdings, Inc. (NASDAQ:GNLN) reported its financial results for the third quarter ended Sept. 30, 2024, disclosing revenue of $4 million compared to $11.8 million in the prior year period.
Greenlane Holdings, Inc. (納斯達克:GNLN) 公佈了截至2024年9月30日的第三季度財務業績，披露營業收入爲400萬美元，而上年同期爲1180萬美元。
The Florida-based cannabis company noted that beginning with its second quarter 2023 earnings release, it implemented a major restructuring of its industrial product lines, transitioning much of this business from gross sales to a commission structure. This change affects how Greenlane reports revenue and enables it to preserve working capital and improve gross margins.
總部位於佛羅里達的大麻公司指出，從2023年第二季度業績開始，該公司對其工業產品線進行了重大改組，將這一業務的很大部分從總銷售額轉換爲佣金結構。這一改變影響了greenlane報告營業收入的方式，使其能夠維持營運資本並提高毛利率。
"During the third quarter, we continued to make progress on strengthening our product strategy and roadmap, enhancing our sales team structure and compensation arrangement, and further extracting operating efficiencies across the enterprise," stated CEO Barbara Sher "We continue to see evidence that our efforts to reposition the business over the last six months have been proving successful. As we enter the next phase of our transformation, we are evolving our product portfolio with the addition of health, safety and wellness products that we believe can broaden our market opportunities and grow revenue."
「在第三季度，我們繼續推進加強產品策略和路線圖、完善銷售團隊架構和薪酬安排，以及在整個企業進一步提取運營效率方面取得進展，」 CEO芭芭拉·謝爾表示：「我們繼續看到，在過去六個月裏重新定位業務的努力正在取得成功。隨着我們進入變革的下一階段，我們正在通過增加健康、安全和健康產品來調整我們的產品組合，我們相信這將擴大我們的市場機會並增加營業收入。」
Read Also: Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion
閱讀更多：大麻股公司Grown Rogue報告第三季度營業收入增長7%，專注於新澤西州和伊利諾伊州的擴張
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
訂閱本新聞快訊，每天免費獲取Benzinga獨家分析和大麻股行業及市場的最新資訊。如果您對業務認真，不容錯過。在這裏訂閱我們的新聞簡報。
Q3 Financial Highlights
Q3財務亮點
- Gross margin percentage increased 48.4% to 75%.
- Gross profit amounted to $3.03 million, compared to $3.13 million in the same period last year.
- Total operating expenses were $3.6 million, a decrease of 64% compared to $10.0 million in the prior year period.
- Operating loss improved by approximately $6.3 million to $538,000 compared to an operating loss of approximately $6.9 million in the prior year period.
- 毛利率增長48.4%，達到75%。
- 毛利潤金額爲$303萬，相比去年同期的$313萬有所下降。
- 總營業費用爲360萬美元，較去年同期的1000萬美元減少了64%。
- 營業虧損改善約630萬美元，達到538,000美元，相比去年同期的約690萬美元的營業虧損有所改喜。
- Net loss was $3.8 million, which included a $3.2 million one-time non-cash charge for interest expense in connection with various merchant cash advances, compared to a net loss of $10.1 million in the prior year period.
- As of September 30, 2024, the company had cash and cash equivalents of approximately $2.3 million.
- 淨損失爲380萬美元，其中包括承擔各種商家現金墊款利息費用的320萬美元一次性非現金費用，相比去年同期的1010萬美元的淨損失。
- 截至2024年9月30日，公司具有約230萬美元的現金及現金等價物。
Recent Milestones
最近的里程碑
In August, Greenlane entered into a securities purchase agreement with a large institutional investor for gross cash proceeds of $6.5 million. Under the agreement, the vendor of cannabis accessories and vaporization products issued 3.36 million units.
今年8月，Greenlane與一家大型機構投資者簽訂了證券購買協議，獲得了650萬美元的總現金收入。根據該協議，大麻配件及汽化產品的供應商發行了336萬個單位。
Earlier the same month, the company announced plans to distribute Safety Strips, Inc.'s fentanyl, xylazine and drink spike detection test strips across the U.S. The company's Safety Strips Fentanyl Test Strip (FTS) ISO 13485 validated product can detect potent synthetic opioids, including 3-methyl Fentanyl, Acetyl Fentanyl, Butyryl Fentanyl, Carfentanil, Fentanyl, Furanyl Fentanyl, Ocfentanil, Remifentanil, Sufentanil, Valeryl Fentanyl, and p-Fluoro Fentanyl. The announcement caused Greenlane's shares to jump 244.40%.
同月早些時候，該公司宣佈計劃在美國分發Safety Strips, Inc.的芬太尼、乙硝唑和飲料摻雜檢測試紙。該公司的Safety Strips芬太尼測試條（FTS）ISO 13485驗證產品可以檢測到多種強效合成阿片類藥物，包括3-甲基芬太尼、乙酰芬太尼、丁酰芬太尼、卡芬太尼、芬太尼、氟苯芬太尼、麻醉芬太尼、瑞芬太尼、舒芬太尼、戊酰芬太尼和對氟芬太尼。該公告導致Greenlane的股價上漲了244.40%。
Price Action
股價變動
Greenlane shares closed Friday market session 6.70% lower at $1.95 per share.
greenlane股在週五閉市時下跌6.70%，每股1.95美元。
- Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
- Avicanna減少淨損失並改善毛利潤，專注於國際市場
Photo: Courtesy of SD_FlowerPower via Shutterstock
照片：由SD_FlowerPower通過Shutterstock提供
譯文內容由第三人軟體翻譯。